Jonathan Havard

Title: Innovations by Jonathan Havard in Gene Delivery

Introduction

Jonathan Havard is an accomplished inventor based in Illkirch-Graffenstaden, France. He has made significant contributions to the field of gene delivery through his innovative research and patent work. His expertise lies in developing compositions that enhance the transfection of nucleic acid molecules into cells.

Latest Patents

Jonathan Havard holds a patent for "Compositions for transfecting a nucleic acid molecule into a cell comprising benzo-fused heterocyclic compounds grafted to a cationic polymer, and their applications." This patent describes compositions that include at least one benzimidazole or benzotriazole compound, which is substituted at a ring nitrogen by a graft cationic polymer. The compositions are designed for in vitro or ex vivo gene delivery, offering high transfection efficiency and reduced cytotoxicity.

Career Highlights

Jonathan is currently associated with Sartorius Polyplus, where he continues to advance his research in gene delivery technologies. His work has been instrumental in developing methods that improve the efficiency of nucleic acid transfection, which is crucial for various biomedical applications.

Collaborations

He collaborates with talented individuals such as Mégane Denu and Malik Hellal, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jonathan Havard's contributions to gene delivery through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in biotechnology and medicine.